Mercedes Macias-Parra

Prof. Mercedes Macias-Parra

Instituto Nacional de Pediatria, Mexico City, Ciudad de México, Mexico

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2006 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
GRGuillermo M. Ruiz-Palacios
Guillermo M. Ruiz-Palacios
IPIrene Pérez-Schael
Irene Pérez-Schael
FVF. Raúl Velázquez
F. Raúl Velázquez
HAHector Abate
Hector Abate
TBThomas Breuer
Thomas Breuer
MOMiguel O´Ryan
Miguel O´Ryan
The safety and efficacy of an attenuated G1P[8] human rotavirus (HRV) vaccine were tested in a randomized, double-blind, phase 3 trial.

1 April 2008 in The Lancet
Verified
Journal Article
Closed access
ALAlexandre C Linhares
Alexandre C Linhares
FVF Raúl Velázquez
F Raúl Velázquez
IPIrene Pérez-Schael
Irene Pérez-Schael
XSXavier Sáez-Llorens
Xavier Sáez-Llorens
HAHector Abate
Hector Abate
ABAlain Bouckenooghe
Alain Bouckenooghe

1 February 2009 in Toxicologic Pathology
Verified
Journal Article
Open access
LClilian calderon-garciduenas
lilian calderon-garciduenas
MMMercedes Macias-Parra
Mercedes Macias-Parra
HHHans J. Hoffmann
Hans J. Hoffmann
GVGildardo Valencia-Salazar
Gildardo Valencia-Salazar
CHCarlos Henríquez-Roldán
Carlos Henríquez-Roldán
RMRobert R. Maronpot
Robert R. Maronpot
Environmental pollutants, chemicals, and drugs have an impact on children’s immune system development. Mexico City (MC) children exposed to significant concentrations of air pollutants exhibit chronic respiratory inflammation, systemic inflammation, neuroinflammation, and cognitive deficits. We tested the hypothesis that exposure to severe air pollution plays a role in the immune responses of asymptomatic, apparently healthy children. Blood measurements for markers of immune function, inflammatory mediators, and molecules interacting with the lipopolysaccharide recognition complex were obtained from two cohorts of matched children (aged 9.7 ± 1.2 years) from southwest Mexico City (SWMC) (n = 66) and from a control city (n = 93) with criteria pollutant levels below current standards. MC children exhibited significant decreases in the numbers of natural killer cells ( p = .003) and increased numbers of mCD14+ monocytes ( p < .001) and CD8+ cells ( p = .02). Lower concentrations of interferon γ ( p = .009) and granulocyte–macrophage colony-stimulating factor ( p < .001), an endotoxin tolerance-like state, systemic inflammation, and an anti-inflammatory response were also present in the highly exposed children. C-reactive protein and the prostaglandin E metabolite levels were positively correlated with twenty-four- and forty-eight-hour cumulative concentrations of PM2.5. Exposure to urban air pollution is associated with immunodysregulation and systemic inflammation in children and is a major health threat.

1 March 2017 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Open access
MDMelissa K. Van Dyke
Melissa K. Van Dyke
JPJean-Yves Pirçon
Jean-Yves Pirçon
RCRobert Cohen
Robert Cohen
SMShabir A. Madhi
Shabir A. Madhi
ARAndrés Rosenblüt
Andrés Rosenblüt
WHWilliam Hausdorff
William Hausdorff
Acute otitis media (AOM) is an important cause of childhood morbidity and antibiotic prescriptions. However, the relative importance of the well-known otopathogens, Streptococcus pneumoniae (Spn) and Haemophilus influenzae (Hflu), remains unclear because of a limited number of tympanocentesis-based studies that vary significantly in populations sampled, case definitions and heptavalent pneumococcal conjugate vaccine use. We conducted a pooled analysis of results from 10 AOM etiology studies of similar design, the protocols of which were derived from a common protocol and conducted in children 3 months to 5 years of age in different countries. Generalized estimating equations were used to account for within-study correlations. The majority, 55.5% (95% confidence interval: 47.0%–65.7%) of 1124 AOM episodes, were bacterial pathogen positive: 29.1% (24.8%–34.1%) yielded Hflu and 23.6% (19.0%–29.2%) Spn. Proportions of Hflu and Spn were higher and lower, respectively, in heptavalent pneumococcal conjugate vaccine–vaccinated children. Hflu and Spn were each isolated from 20% to 35% of children in every 1-year age range. Hflu was less likely to be isolated from first (vs. subsequent) episodes [relative risk (RR): 0.71 (0.60–0.84)]. Spn was more often isolated from sporadic (vs. recurrent) cases [RR: 0.76 (0.61–0.97)]; the opposite was true for Hflu [RR: 1.4 (1.00–1.96)]. Spn cases were more likely to present with severe (vs. mild) symptoms [RR: 1.42 (1.01–2.01)] and Hflu cases with severe tympanic membrane inflammation [RR: 1.35 (1.06–1.71)]. Spn and Hflu remain the leading otopathogens in all populations examined. While associated with overlapping symptoms and severity, they exhibit some differences in their likelihood to cause disease in specific subpopulations.

27 May 2013 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
XSXavier Sáez-Llorens
Xavier Sáez-Llorens
FVF Raúl Velázquez
F Raúl Velázquez
PLPio Lopez
Pio Lopez
FEFelix Espinoza
Felix Espinoza
ALAlexandre C Linhares
Alexandre C Linhares
TBThomas Breuer
Thomas Breuer
Background: Intussusception (IS) is a form of acute intestinal obstruction that occurs mainly in infants and is usually of unknown cause. An association between IS and the first licensed rotavirus vaccine, a reassortant-tetravalent, rhesus-based rotavirus vaccine (RRV-TV), led to the withdrawal of the vaccine. New rotavirus vaccines have now been developed and extensively studied for their potential association with IS. This study aimed to describe the epidemiology and to estimate the incidence of IS in Latin American infants prior to new vaccine introduction. Methods: Children under 2 years of age representing potential IS cases were enrolled in 16 centers in 11 Latin American countries from January 2003 to May 2005. IS cases were classified as definite, probable, possible or suspected as stated on the Brighton Collaboration Working Group guidelines. Results: From 517 potential cases identified, 476 (92%) cases were classified as definite, 21 probable, 10 possible and 10 suspected for intussusception. Among the 476 definite IS cases, the median age at presentation was 6.4 months with 89% of cases aged <1 year. The male to female ratio was 1.5:1. The incidence of definite IS per 100,000 subject-years ranged from 1.9 in Brazil to 62.4 in Argentina for children <2 years of age, and from 3.8 in Brazil to 105.3 in Argentina for children aged <1 year. Median hospital stay was 4 days with a high prevalence of surgery as the primary treatment (65%). Most cases (88%) made a complete recovery, but 13 (3%) died. No clear seasonal pattern of IS cases emerged. Conclusions: This study describes the epidemiology and estimates the incidence of IS in Latin American infants prior to the introduction of new rotavirus vaccines. The incidence of IS was found to vary between different countries, as observed in previous studies. Trial registration: Clinical study identifier 999910/204 (SERO-EPI-IS-204)

1 July 2011 in Vaccine
Verified
Journal Article
Closed access
MMMercedes Macias-Parra
Mercedes Macias-Parra
GAGerardo Martinez Aguilar
Gerardo Martinez Aguilar
GEGabriela Echaniz-Aviles
Gabriela Echaniz-Aviles
RRRomulo Galo Rionda
Romulo Galo Rionda
MEMaria de Los Angeles Meza Estrada
Maria de Los Angeles Meza Estrada
WHWilliam P. Hausdorff
William P. Hausdorff